增加循环中的前列腺素不足以诱导心脏功能障碍或心室上心律失常
Kevin E McElhanon1, Tyler C Huff1, Dinesh Hirenallur-Shanthappa2
1Rare Disease Research Unit, Worldwide Research, Development, and Medical, Pfizer, Inc., Cambridge, MA, USA.
Scientific reports
|December 6, 2023
概括
在小鼠中,蛋白质progranulin (PGRN) 的水平增加并没有引起心房动或影响心脏功能. 这项研究表明,PGRN不是导致肥胖相关心律不整的直接原因.
科学领域:
- 心脏病学 心脏病学
- 生物化学 生物化学
- 分子生物学分子生物学
背景情况:
- 心房动 (AF) 是一种常见的心律失常,发病率越来越高.
- 肥胖是一个日益严重的公共卫生问题,也是AF的危险因素.
- 与肥胖相关的AF中循环蛋白质,如progranulin的作用正在调查中.
研究的目的:
- 为了研究循环中高水平的前列腺素对脑上节律失常的影响.
- 评估增加的前列腺素对心脏结构和功能的影响.
主要方法:
- 在C57Bl/6N小鼠中,腺相关病毒血清型8 (AAV8) 介导的小鼠前列素过度表达.
- 在20周内维持高血progranulin水平.
- 心脏电生理学通过表面心电图与异二醇挑战进行评估.
- 使用心声学评估心脏结构和功能.
主要成果:
- 证实了循环中的益格拉努林水平持续升高.
- 没有观察到心脏结构或功能的显著变化.
- 心电图 (ECG) 参数没有受到影响.
- 没有超心室节律失常或前节律事件是由异二醇诱导的.
结论:
- 在这种小鼠模型中,仅仅循环中的高水平的前列腺素不足以诱导心脏结构或功能变化.
- 增加的progranulin水平并没有导致心电图异常或增加对心室外心律不整的敏感性.
- 需要进一步的研究来阐明肥胖,前列素和心房动之间的复杂关系.
相关概念视频
Heart Failure Drugs: Inotropic Agents
594
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
594
Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
96
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
96
GPCRs Regulate Adenylyl Cylase Activity
5.6K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.6K


